Nyanda Elias Ntinginya

机构：Dar es Salaam Institute of Technology, Mbeya University of Science and Technology, Institut National de Recherche en Santé Publique, National Institute for Medical Research · ORCID：0000-0002-1575-4521

发表论文 187 篇 · 总被引 3379 次 · h-index 25

代表论文

• Sutezolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-SUDOCU-01): a prospective, open-label, randomised, phase 2b dose-finding trial (2025 · The Lancet Infectious Diseases · 被引 19)
• Delpazolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-DECODE-01): a prospective, randomised, open-label, phase 2b, dose-finding trial (2025 · The Lancet Infectious Diseases · 被引 18)
• Ebola virus vaccination elicits Ebola virus–specific immune responses without substantial cross-reactivity to other filoviruses (2025 · Science Translational Medicine · 被引 12)
• Profiling of HIV-1 elite neutralizer cohort reveals a CD4bs bnAb for HIV-1 prevention and therapy (2025 · Nature Immunology · 被引 7)
• The pattern change of hepatitis B virus genetic diversity in Northwestern Tanzania (2025 · Scientific Reports · 被引 7)
• The Costs of Digital Health Interventions to Improve Immunization Data in Low- and Middle-Income Countries: Multicountry Mixed Methods Study (2025 · Journal of Medical Internet Research · 被引 5)